TactiCath Post Market Approval Study

Recruiting
18 years - 100 years
All
Phase
4
35 participants needed
1 Location
Brief description of study
The purpose of the research study is to obtain additional information safety and effectiveness of an FDA approved catheter when used to treat patients with Paroxysmal atrial fibrillation.
Detailed description of study
The purpose of the study is to provide data and safety for the Food and Drug administration (FDA). The study is designed for patients with paroxysmal atrial fibrillation. Participants will only be enrolled if at the time of consent present with paroxysmal atrial fibrillation and meet criteria for an ablation procedure. The study is seeking participants willing to be followed for a period of 5 years
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Atrial Fibrillation
-
Age: 18 years - 100 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 821652